Pipeline

    Pipeline

      • Oncology Oncology

        Our oncology pipeline is grounded in a deep understanding of tumor biology and drug resistance mechanisms, combined with a sustained pursuit of​ innovative drug design strategies.

      • Infectious diseases Infectious diseases

        Our infectious disease pipeline is dedicated to developing broad-spectrum, small-molecule antiviral drugs. Target indications include epidemic diseases such as coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome (SARS), and Middle East respiratory syndrome (MERS).

      在研管线列表
      Compound Name
      Therapeutic Area
      Target
      Drug Discovery
      药物优化
      Preclinical
      Phase 1
      Phase 2
      Phase 3
      Marketed
      WPV01 Read More
      COVID-19
      3CLpro
      WPV02 Read More
      病毒
      3CLpro
      WPV03 Read More
      病毒
      RdRp
      WPC01 Read More
      肿瘤
      MAPK Pathway
      WPC02 Read More
      肿瘤
      MAPK Pathway
      WPC03 Read More
      肿瘤
      MAPK Pathway
      WPC04 Read More
      肿瘤
      MAPK Pathway
      WPC05 Read More
      肿瘤
      MAPK Pathway
      WPC06 Read More
      肿瘤
      Epigenetics and Transcription Factors
      WPC07 Read More
      肿瘤
      Epigenetics and Transcription Factors
      WPC08 Read More
      肿瘤
      Epigenetics and Transcription Factors